EGFR and non-small cell lung carcinoma: For example, FAR β-targeted pH-sensitive liposomes containing docetaxel prepared by Park et al. [57] and EGFR-targeted theranostic liposome co-loaded with DNA-biodots and etoposide reported by Jha et al. [58] demonstrated stronger tumor suppression effects for NSCLC.